Ha habido 50 transacciones internas recientes registradas para Oncternal Therapeutics, Inc. (ONCT), incluyendo 34 compras y 16 ventas. El total de compras internas fue valorado en $1.01M y el total de ventas internas en $1.35M.
Internos destacados con actividad reciente incluyen Hale David F, Kisner Daniel L, Larue William R. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ONCT
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-06-20 |
Hale David F |
Director |
Concesión de RSU |
3,300 |
$8.10 |
$26.73K |
3,300 |
| 2024-06-20 |
Kisner Daniel L |
Director |
Concesión de RSU |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Larue William R |
Director |
Concesión de RSU |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Carter Michael G |
Director |
Concesión de RSU |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Mazanet Rosemary |
Director |
Concesión de RSU |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Theuer Charles |
Director |
Concesión de RSU |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Wills Robert James |
Director |
Concesión de RSU |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-06-20 |
Desimone Jill |
Director |
Concesión de RSU |
2,200 |
$8.10 |
$17.82K |
2,200 |
| 2024-04-08 |
Wills Robert James |
Director |
Compra Informativa |
3,086 |
$8.96 |
$27.65K |
10,000 |
| 2024-03-28 |
Wills Robert James |
Director |
Compra Informativa |
6,914 |
$8.48 |
$58.6K |
6,914 |
| 2024-02-23 |
Hale David F |
Director |
Compra Informativa |
714 |
$9.04 |
$6.45K |
714 |
| 2024-02-23 |
Wills Robert James |
Director |
Venta Informativa |
980 |
$9.04 |
$8.86K |
- |
| 2024-02-14 |
Breitmeyer James B |
Chief Executive Officer |
Concesión de RSU |
6,200 |
$9.18 |
$56.92K |
6,200 |
| 2024-02-14 |
Vincent Richard G |
Chief Financial Officer |
Concesión de RSU |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Leavitt Chase C. |
General Counsel/secretary |
Concesión de RSU |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Yazji Salim |
Chief Medical Officer |
Concesión de RSU |
14,200 |
$9.18 |
$130.36K |
14,200 |
| 2024-02-14 |
Krishnan Rajesh |
CTO/cso |
Concesión de RSU |
17,700 |
$9.18 |
$162.49K |
17,700 |
| 2024-01-03 |
Breitmeyer James B |
Chief Executive Officer |
Retención Fiscal de RSU |
4,485 |
$0.50 |
$2.23K |
15,426 |
| 2024-01-03 |
Vincent Richard G |
Chief Financial Officer |
Retención Fiscal de RSU |
8,868 |
$0.50 |
$4.4K |
140,922 |
| 2024-01-03 |
Leavitt Chase C. |
General Counsel/secretary |
Retención Fiscal de RSU |
11,838 |
$0.50 |
$5.87K |
84,758 |
| 2024-01-03 |
Yazji Salim |
Chief Medical Officer |
Retención Fiscal de RSU |
19,742 |
$0.50 |
$9.79K |
128,635 |
| 2024-01-03 |
Krishnan Rajesh |
Chief Technical Officer |
Retención Fiscal de RSU |
11,838 |
$0.50 |
$5.87K |
44,019 |
| 2023-10-02 |
Breitmeyer James B |
Chief Executive Officer |
Devolución de Acciones |
100,000 |
$5.76 |
$576K |
- |
| 2023-10-02 |
Vincent Richard G |
Chief Financial Officer |
Devolución de Acciones |
210,000 |
$0.96 |
$201.6K |
- |
| 2023-10-02 |
Leavitt Chase C. |
General Counsel/secretary |
Devolución de Acciones |
55,519 |
$1.94 |
$107.71K |
- |
| 2023-10-02 |
Yazji Salim |
Chief Medical Officer |
Devolución de Acciones |
210,000 |
$0.96 |
$201.6K |
- |
| 2023-10-02 |
Krishnan Rajesh |
Chief Technical Officer |
Devolución de Acciones |
220,000 |
$0.96 |
$211.2K |
- |
| 2023-07-03 |
Breitmeyer James B |
Chief Executive Officer |
Retención Fiscal de RSU |
4,007 |
$0.36 |
$1.44K |
19,911 |
| 2023-07-03 |
Vincent Richard G |
Chief Financial Officer |
Retención Fiscal de RSU |
7,069 |
$0.36 |
$2.54K |
149,790 |
| 2023-07-03 |
Leavitt Chase C. |
General Counsel/secretary |
Retención Fiscal de RSU |
10,305 |
$0.36 |
$3.71K |
96,596 |
| 2023-07-03 |
Yazji Salim |
Chief Medical Officer |
Retención Fiscal de RSU |
16,299 |
$0.36 |
$5.87K |
148,377 |
| 2023-07-03 |
Krishnan Rajesh |
Chief Technology Officer |
Retención Fiscal de RSU |
10,897 |
$0.36 |
$3.92K |
55,857 |
| 2023-06-28 |
Hale David F |
Director |
Concesión de RSU |
37,500 |
$0.36 |
$13.32K |
37,500 |
| 2023-06-28 |
Kisner Daniel L |
Director |
Concesión de RSU |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Larue William R |
Director |
Concesión de RSU |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Carter Michael G |
Director |
Concesión de RSU |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Mazanet Rosemary |
Director |
Concesión de RSU |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Theuer Charles |
Director |
Concesión de RSU |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Wills Robert James |
Director |
Concesión de RSU |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Nakanishi Xin |
Director |
Concesión de RSU |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-28 |
Desimone Jill |
Director |
Concesión de RSU |
25,000 |
$0.36 |
$8.88K |
25,000 |
| 2023-06-14 |
Kaufmann Gunnar F. |
Chief Scientific Officer |
Compra Informativa |
3,000 |
$0.36 |
$1.08K |
94,726 |
| 2023-06-12 |
Kaufmann Gunnar F. |
Chief Scientific Officer |
Compra Informativa |
25,000 |
$0.35 |
$8.75K |
91,726 |
| 2023-04-14 |
Yazji Salim |
Chief Medical Officer |
Compra Informativa |
5,000 |
$0.30 |
$1.5K |
164,676 |
| 2023-04-14 |
Breitmeyer James B |
Chief Executive Officer |
Compra Informativa |
47,750 |
$0.30 |
$14.28K |
194,294 |
| 2023-04-13 |
Vincent Richard G |
Chief Financial Officer |
Compra Informativa |
30,000 |
$0.30 |
$8.96K |
156,859 |
| 2023-04-13 |
Leavitt Chase C. |
General Counsel/secretary |
Compra Informativa |
10,000 |
$0.29 |
$2.9K |
106,901 |
| 2023-04-13 |
Yazji Salim |
Chief Medical Officer |
Compra Informativa |
10,000 |
$0.29 |
$2.85K |
159,676 |
| 2023-04-13 |
Breitmeyer James B |
Chief Executive Officer |
Compra Informativa |
100,000 |
$0.29 |
$29K |
146,544 |
| 2023-04-12 |
Leavitt Chase C. |
General Counsel/secretary |
Compra Informativa |
15,000 |
$0.29 |
$4.35K |
96,901 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
